
Sign up to save your podcasts
Or


Vidcast: https://youtu.be/nsq6RTRCqbk
Here are the quickie reports about cutting edge medical and healthcare discoveries this 1st Week of August, 2022.
Neuroblastoma, the development of cancer in the involuntary nervous system, is a deadly disease for children 5 years and younger. Now a group of biologists at Virginia Commonwealth University have identified a compound called SHP099 that blocks the enzymatic activation of the MEK/ERK proteins that potentiate the growth of these tumors. The best news is that even high doses of SHP099 have little effect on normal cells. The compound shrinks neuroblastoma tumors in mice and, hopefully someday, will also do so in children.
https://bit.ly/3PNhduj
MIT mechanical bioengineers have developed a wearable sticker capable of providing continuous, live ultrasound images. These stamp-sized devices mate arrays of ultrasound transducers with adhesives and capably create images of underlying organs for up to 48 hours. Currently, the patches must be wired to the imaging processors but, in the future, wireless versions may transmit to mobile processors to permit continuous ultrasound monitoring of body organs and developing babies.
https://www.science.org/doi/10.1126/science.abo2542
Those awaiting heart transplants often need a boost in the pumping function provided by their own flagging hearts. Traditionally, that requires an implantable pump, a so-called left ventricular assist device, to be surgically inserted into the left ventricle during an open heart procedure. The Mayo Clinic now offers another option, a heart pumping a catheter called the Impella 5.5 that is non-invasively introduced into the heart via an armpit vessel. The device pumps blood out of the left ventricle into the aorta taking the load off the heart muscle. An added bonus: having this catheter pump pushes a transplant candidate higher up on the list.
https://www.mayoclinic.org/medical-professionals/transplant-medicine/news/mayo-clinic-in-florida-first-hospital-in-the-world-to-use-a-new-heart-pump-as-bridge-to-transplant/mac-20519622
A prickly skin patch not only delivers CoVid vaccine without the dreaded hypodermic syringe feared by the needle-phobic, but it also triggers a higher level of CoVid protection. Australian researchers report that a protein-subunit CoVid vaccine triggers 11 fold higher levels of neutralizing antibodies against the Omicron variant when administered via a high density needle microarray patch compared with a conventional intradermal needle injection.
https://www.sciencedirect.com/science/article/pii/S0264410X2200888X?via%3Dihub
There you have the latest health reveals for this 1st Week of August, 2022, 2022. When additional information about these developments becomes available,
By Howard G. Smith MD, AM
Vidcast: https://youtu.be/nsq6RTRCqbk
Here are the quickie reports about cutting edge medical and healthcare discoveries this 1st Week of August, 2022.
Neuroblastoma, the development of cancer in the involuntary nervous system, is a deadly disease for children 5 years and younger. Now a group of biologists at Virginia Commonwealth University have identified a compound called SHP099 that blocks the enzymatic activation of the MEK/ERK proteins that potentiate the growth of these tumors. The best news is that even high doses of SHP099 have little effect on normal cells. The compound shrinks neuroblastoma tumors in mice and, hopefully someday, will also do so in children.
https://bit.ly/3PNhduj
MIT mechanical bioengineers have developed a wearable sticker capable of providing continuous, live ultrasound images. These stamp-sized devices mate arrays of ultrasound transducers with adhesives and capably create images of underlying organs for up to 48 hours. Currently, the patches must be wired to the imaging processors but, in the future, wireless versions may transmit to mobile processors to permit continuous ultrasound monitoring of body organs and developing babies.
https://www.science.org/doi/10.1126/science.abo2542
Those awaiting heart transplants often need a boost in the pumping function provided by their own flagging hearts. Traditionally, that requires an implantable pump, a so-called left ventricular assist device, to be surgically inserted into the left ventricle during an open heart procedure. The Mayo Clinic now offers another option, a heart pumping a catheter called the Impella 5.5 that is non-invasively introduced into the heart via an armpit vessel. The device pumps blood out of the left ventricle into the aorta taking the load off the heart muscle. An added bonus: having this catheter pump pushes a transplant candidate higher up on the list.
https://www.mayoclinic.org/medical-professionals/transplant-medicine/news/mayo-clinic-in-florida-first-hospital-in-the-world-to-use-a-new-heart-pump-as-bridge-to-transplant/mac-20519622
A prickly skin patch not only delivers CoVid vaccine without the dreaded hypodermic syringe feared by the needle-phobic, but it also triggers a higher level of CoVid protection. Australian researchers report that a protein-subunit CoVid vaccine triggers 11 fold higher levels of neutralizing antibodies against the Omicron variant when administered via a high density needle microarray patch compared with a conventional intradermal needle injection.
https://www.sciencedirect.com/science/article/pii/S0264410X2200888X?via%3Dihub
There you have the latest health reveals for this 1st Week of August, 2022, 2022. When additional information about these developments becomes available,